Development Programs | Indication | Preclinical | Phase 1 | Phase 2 | Phase 3 | Status |
---|---|---|---|---|---|---|
VK2809 (TRβ Agonist) | NASH |
|
Phase 2b VOYAGE trial ongoing | |||
VK2735 (Dual GLP-1/GIP agonist) | Obesity |
|
Phase 2 VENTURE study ongoing | |||
VK2735 Oral (Dual GLP-1/GIP agonist) | Metabolic disorders |
|
Phase 1 ongoing | |||
VK0214 (TRβ Agonist) | X-ALD |
|
Phase 1b ongoing |